Osteoprotegerin, RANK, RANKL
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
12426773
DOI
10.5507/bp.2001.013
Knihovny.cz E-resources
- MeSH
- Glycoproteins physiology MeSH
- Humans MeSH
- RANK Ligand MeSH
- Membrane Glycoproteins physiology MeSH
- Osteoclasts physiology MeSH
- Osteoprotegerin MeSH
- Receptor Activator of Nuclear Factor-kappa B MeSH
- Receptors, Cytoplasmic and Nuclear physiology MeSH
- Receptors, Tumor Necrosis Factor MeSH
- Carrier Proteins physiology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Glycoproteins MeSH
- RANK Ligand MeSH
- Membrane Glycoproteins MeSH
- Osteoprotegerin MeSH
- Receptor Activator of Nuclear Factor-kappa B MeSH
- Receptors, Cytoplasmic and Nuclear MeSH
- Receptors, Tumor Necrosis Factor MeSH
- TNFRSF11A protein, human MeSH Browser
- TNFRSF11B protein, human MeSH Browser
- TNFSF11 protein, human MeSH Browser
- Carrier Proteins MeSH
Osteoprotegerin, RANK (Receptor Activator of Nuclear factor kappa B) and RANKL (Receptor Activator of Nuclear faktor kappa B ligand) became the aim of intensive research. RANK is considered as a hematopoietic surface receptor controlling osteoclastogenesis and calcium metabolism. RANKL may promote osteoresorption by induction of cathepsin K gene expression. The present paper summarizes the most significant data in osteoprotegerin, RANK and RANKL problems obtained.
References provided by Crossref.org
